NUP210 and primary biliary cholangitis: A significantly greater number of patients in the SS + PBC group were positive for ACA, AMA-M2, AMA, anti-3E, and anti-gp210 antibodies (P < 0.05) than those in the SS-only group, whereas no significant difference was observed for other antibodies.